Objective: To estimate the frequency of vitamin D deficiency in patients with newly diagnosed pulmonary tuberculosis
in Khyber Pukntunkhwa.
tuberculosis (MTB).5 Active pulmonary tuberculosis
(PTB) cases are the key agent for the burden of disease.
In the current study, we have assessed the diagnostic value of ADA in sputum in patients with suspected pulmonary tuberculosis
"Clinical Manifestation of Extra Pulmonary Tuberculosis
In the setting of an overall prevalence of culture-confirmed pulmonary tuberculosis
of 22.4% (14.2% [88 of 618] in the United States and 37.1% [127 of 342] outside the United States), a single negative Xpert MTB/RIF Assay result predicted the absence of AFB smear-positive pulmonary tuberculosis
with a negative predictive value of 99.7% (99.6%% in the United States and 100% outside the United States); for two serial negative Xpert MTB/RIF Assay results, the negative predictive value was 100%.
This prospective (descriptive-analytic) study was carried out on all pulmonary tuberculosis
patients who attended Birjand Tuberculosis Center during 2010-2011.
Randomized controlled trial of zinc and Vitamin A as co-adjuvants for the treatment of pulmonary tuberculosis
. Trop Med Int Health 2010;15:1481-90.
Symptoms of pulmonary tuberculosis
include productive, prolonged cough of three or more weeks, chest pain and hemoptysis.
(15) Though pulmonary tuberculosis
has been reported in the vast majority of publications, extra-pulmonary tuberculosis is also described.
[sup],,, Very few cases of concurrent KS and pulmonary tuberculosis
(PTB) have been described in the English literature.
This report provides comprehensive information on the therapeutic development for Pulmonary Tuberculosis
, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
This retrospective cohort study was conducted on inpatient new cases of pulmonary tuberculosis
that were diagnosed in the National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran between 2005 and 2009.